These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 14522358

  • 1. Buspirone differentially modifies short-term memory function in a combined delayed matching/non-matching to position task.
    Pache DM, Fernández-Pérez S, Sewell RD.
    Eur J Pharmacol; 2003 Sep 23; 477(3):205-11. PubMed ID: 14522358
    [Abstract] [Full Text] [Related]

  • 2. Co-administration of fluoxetine and WAY100635 improves short-term memory function.
    Fernández-Pérez S, Pache DM, Sewell RD.
    Eur J Pharmacol; 2005 Oct 17; 522(1-3):78-83. PubMed ID: 16214127
    [Abstract] [Full Text] [Related]

  • 3. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.
    de Bortoli VC, Nogueira RL, Zangrossi H.
    Psychopharmacology (Berl); 2006 Jan 17; 183(4):422-8. PubMed ID: 16258751
    [Abstract] [Full Text] [Related]

  • 4. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure.
    Body S, Chiang TJ, Mobini S, Ho MY, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2001 Nov 17; 158(3):305-13. PubMed ID: 11713621
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
    Zhang Z, Rickard JF, Body S, Asgari K, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2005 Sep 17; 181(2):381-91. PubMed ID: 15830225
    [Abstract] [Full Text] [Related]

  • 6. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF, Fozard JR.
    Br J Pharmacol; 1990 Feb 17; 99(2):343-9. PubMed ID: 1970269
    [Abstract] [Full Text] [Related]

  • 7. Detecting drug effects on short-term memory function using a combined delayed matching and non-matching to position task.
    Pache DM, Sewell RD, Spencer PS.
    J Pharmacol Toxicol Methods; 1999 Aug 17; 41(4):135-41. PubMed ID: 10691017
    [Abstract] [Full Text] [Related]

  • 8. Behavioral and neurochemical effects of the serotonin (5-HT)1A receptor ligand spiroxatrine.
    Barrett JE, Hoffmann SM, Olmstead SN, Foust MJ, Harrod C, Weissman BA.
    Psychopharmacology (Berl); 1989 Aug 17; 97(3):319-25. PubMed ID: 2524083
    [Abstract] [Full Text] [Related]

  • 9. Role of 5-HT(1A)- and 5-HT(2A) receptors for the murine model of the serotonin syndrome.
    Haberzettl R, Fink H, Bert B.
    J Pharmacol Toxicol Methods; 2014 Aug 17; 70(2):129-33. PubMed ID: 25087754
    [Abstract] [Full Text] [Related]

  • 10. Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats.
    Nayebi AM, Rad SR, Saberian M, Azimzadeh S, Samini M.
    Pharmacol Rep; 2010 Aug 17; 62(2):258-64. PubMed ID: 20508280
    [Abstract] [Full Text] [Related]

  • 11. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 12. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P, Lesourd M, Comoy E.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353
    [Abstract] [Full Text] [Related]

  • 13. 5-HT-1A receptor responsiveness following subchronic administration of buspirone.
    Khan A, Haleem DJ.
    Pak J Pharm Sci; 2006 Oct 10; 19(4):333-7. PubMed ID: 17105715
    [Abstract] [Full Text] [Related]

  • 14. Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression.
    Rhoads DE, Grimes N, Kaushal S, Mallari J, Orlando K.
    Pharmacol Biochem Behav; 2012 Jul 10; 102(1):58-63. PubMed ID: 22494991
    [Abstract] [Full Text] [Related]

  • 15. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK, Naumenko VS, Cybko AS, Bazovkina DV.
    Neuroscience; 2010 Aug 11; 169(1):229-35. PubMed ID: 20423722
    [Abstract] [Full Text] [Related]

  • 16. Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635.
    Newman ME, Shalom G, Ran A, Gur E, Van de Kar LD.
    Eur J Pharmacol; 2004 Feb 13; 486(1):25-30. PubMed ID: 14751404
    [Abstract] [Full Text] [Related]

  • 17. GR46611 potentiates 5-HT1A receptor-mediated locomotor activity in the guinea pig.
    O'Neill MF, Sanger GJ.
    Eur J Pharmacol; 1999 Apr 09; 370(2):85-92. PubMed ID: 10323255
    [Abstract] [Full Text] [Related]

  • 18. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
    Haleem DJ, Shireen E, Haleem MA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 09; 28(8):1323-9. PubMed ID: 15588759
    [Abstract] [Full Text] [Related]

  • 19. Activation of serotonergic 5-HT(1A) receptors in the lateral parabrachial nucleus increases NaCl intake.
    De Gobbi JI, Barbosa SP, De Luca LA, Thunhorst RL, Johnson AK, Menani JV.
    Brain Res; 2005 Dec 20; 1066(1-2):1-9. PubMed ID: 16360657
    [Abstract] [Full Text] [Related]

  • 20. 5-HT1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task.
    Cole BJ, Jones GH, Turner JD.
    Psychopharmacology (Berl); 1994 Oct 20; 116(2):135-42. PubMed ID: 7862942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.